Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-35
SponsorNicholas Breitborde
About this trial
Single-blind, randomized controlled trial of normobaric oxygen therapy among individuals with first-episode psychosis: Effects on symptomatology and cognition.
Eligibility criteria
Qualifiers
Diagnosis of a schizophrenia-spectrum disorder or mood disorder with psychotic features as determined using the Structured Clinical Interview for the DSM-5.
Less than 5 years since the onset of frank psychotic symptoms as determined using the Symptom Onset in Schizophrenia Inventory .
No evidence of a pre-existing intellectual disability defined as a premorbid IQ >70 as estimated using the Reading subtest of the Wide Range Achievement Test-4.
Ages 15-35
Disqualifiers
None
Trial design
Treatments tested in this trial
- Normobaric Oxygen
- Placebo
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Nicholas Breitborde
Lead sponsor
Ohio State University
Sponsor institution
Source ClinicalTrials.gov